These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12719667)

  • 21. Eye disorders: bacterial conjunctivitis.
    Chung CW; Cohen EJ
    West J Med; 2000 Sep; 173(3):202-5. PubMed ID: 10986192
    [No Abstract]   [Full Text] [Related]  

  • 22. New antibacterial drugs for topical ophthalmic use.
    Yolton DP
    Optom Clin; 1992; 2(4):59-72. PubMed ID: 1286241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
    Friedlaender MH
    CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norfloxacin ophthalmic versus chloramphenicol in bacterial conjunctivitis and blepharoconjunctivitis.
    Avisar R; Vender T; Savir H; Lerner N; Hundart O; Yasur Y
    DICP; 1990 Jun; 24(6):640-1. PubMed ID: 2360342
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin.
    Amaro Martins VC; Goissis G
    Artif Organs; 2000 Mar; 24(3):224-30. PubMed ID: 10759646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant Infantile Bacterial Conjunctivitis in Egypt: A Microbiology Study.
    Hashish AA; Elbakary MA; Allam WA
    J Pediatr Ophthalmol Strabismus; 2018 Mar; 55(2):135-139. PubMed ID: 29131910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies.
    Charoo NA; Kohli K; Ali A; Anwer A
    Drug Dev Ind Pharm; 2003 Feb; 29(2):215-21. PubMed ID: 12648018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora.
    Leeming JP; Diamond JP; Trigg R; White L; Hoh HB; Easty DL
    Br J Ophthalmol; 1994 Jul; 78(7):546-8. PubMed ID: 7918266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group.
    Miller IM; Vogel R; Cook TJ; Wittreich J
    Am J Ophthalmol; 1992 Jun; 113(6):638-44. PubMed ID: 1598954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
    Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute bacterial conjunctivitis - antibiotic susceptibility and resistance to commercially available topical antibiotics in Nepal.
    Shrestha SP; Khadka J; Pokhrel AK; Sathian B
    Nepal J Ophthalmol; 2016 Jan; 8(15):23-35. PubMed ID: 28242882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ; Hobden JA; Hill JM; Forman K; O'Callaghan RJ
    Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute bacterial conjunctivitis with topical netilmicin.
    Papa V; Aragona P; Scuderi AC; Blanco AR; Zola P; Di BA; Santocono M; Milazzo G
    Cornea; 2002 Jan; 21(1):43-7. PubMed ID: 11805506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption of ciprofloxacin and norfloxacin when administered as niosome-encapsulated inclusion complexes.
    D'Souza SA; Ray J; Pandey S; Udupa N
    J Pharm Pharmacol; 1997 Feb; 49(2):145-9. PubMed ID: 9055185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of norfloxacin in bacterial conjunctivitis.
    Huber-Spitzy V; Arocker-Mettinger E; Baumgartner I
    Eur J Ophthalmol; 1991; 1(2):69-72. PubMed ID: 1821203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chlamydial conjunctivitis].
    Aznabaev MT; Latypova EA; Babushkin AE
    Vestn Oftalmol; 2001; 117(5):51-2. PubMed ID: 11765472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four cases of Raoultella planticola conjunctivitis.
    Vassallo J; Vella M; Cassar R; Caruana P
    Eye (Lond); 2016 Apr; 30(4):632-4. PubMed ID: 26742869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
    Charoo NA; Kohli K; Ali A
    J Pharm Sci; 2003 Feb; 92(2):407-13. PubMed ID: 12532390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol.
    Power WJ; Collum LM; Easty DL; Bloom PA; Laidlaw DA; Libert J; Sangers D; Wuokko M; Saksela T
    Eur J Ophthalmol; 1993; 3(2):77-82. PubMed ID: 8353434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.